Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20110313006044N2Phase 3Completed
Phase 3 trial of dexmedetomidine and fentanyl in procedural pain (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Effect on spinal analgesia. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20110313006044N2.